<DOC>
	<DOCNO>NCT02853942</DOCNO>
	<brief_summary>Main purpose：In face listen nerve injury early stage , utilize autologous adipose stem cell transplantation treatment make acceptance micro vascular decompression hemifacial spasm patient nerve function obtain good recovery . Secondary purpose ：To clarify efficacy stem cell treatment cranial nerve dysfunction , provide evidence treatment cranial nerve dysfunction . Cases group：Appearing surface microvascular decompression hemifacial spasm decrease neural electrophysiological index patient research design：Single center , prospective , randomize , double-blind , control Observation index：Facial nerve clinical score , facial nerve muscle compound action potential , electrical measurement , cerebrospinal fluid index Evaluation therapeutic effect：Facial nerve function evaluation ( House-Brackmann classification , facial nerve function classification scale SFGS ) , facial nerve electrophysiology evaluation ( facial nerve muscle compound action potential ) , electric measurement Safety evaluation：Clear evaluation hemifacial spasm micro vascular decompression listen nerve intracranial segment wrap around autologous fat stem cell therapy overall safety evaluation method include adverse event , laboratory test , vital sign , electrocardiogram .</brief_summary>
	<brief_title>Autologous Adipose Mesenchymal Stem Cell Transplantation Treatment Patients With Hemifacial Spasm</brief_title>
	<detailed_description />
	<mesh_term>Hemifacial Spasm</mesh_term>
	<mesh_term>Facial Nerve Injuries</mesh_term>
	<criteria>1. age 18 ~ 80 year old ; 2. surgical contraindication , accept facial nerve microvascular decompression surgery ; 3. enter group 's informed consent sign consent form clinical research . 4. patient preoperative facial nerve electrophysiology examination without facial paralysis 5. patient preoperative electrical test without hear impairment 1. patient poor compliance ; 2. major surgical complication interruption treatment ; 3. brain magnetic resonance examination blood test result abnormal clinical significance ; 4. clinical trial drug within 30 day ; 5. unintended side effect ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>